Michael Stark: How Glucocorticoids in Pregnancy Affect Fetal Development and Why It Matters
Michael Stark, Professor of Neonatal Medicine and Deputy Director of Clinical Research at the Robinson Research Institute, Director of Neonatal Medicine at the University of Adelaide and Head of Neonatal Services at the Women’s and Children’s Hospital Adelaide, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Endocrine Reviews, adding:
“Our latest article about the critical role of glucocorticoids in pregnancy and the importance of understanding the underlying mechanisms of how they effect the fetus.
A significant step towards identifying ‘responsive subgroups‘ to optimise antenatal steroid therapy and move away from a simplistic one-size-fits-all approach to management of preterm birth.”
Title: Glucocorticoids in pregnancy: A master-switch for fetal maturation
Authors: Yoshi Tan, Michael J Stark, Vicki L Clifton, Michael D Wiese, Janna L Morrison, Kathryn L Gatford
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 31, 2026, 14:03Adil Aftab: Anticoagulation in CKD – Key Updates from the 2026 ESC Guidelines
-
Aug 31, 2026, 14:01Isa Oboirien: Why Might Factor XI Inhibition Work Differently in Stroke and ACS?
-
Aug 31, 2026, 13:55Mike Morrissey: Advancing Europe’s Cardiovascular Health Agenda at ESC Congress 2026
-
Aug 31, 2026, 13:44Penilla Gunther: Patient Voices Take Center Stage in Cardiovascular Prevention at ESC Congress 2026
-
Aug 31, 2026, 13:42Mohamed Saleh Gomaa: Master the Latest in PE Management
-
Aug 31, 2026, 13:38Lyn Kleinbach-Reilly: A New Standard for Coagulation Testing in Neonatal Care
-
Aug 31, 2026, 13:36Rafael Gomes: Can Prasugrel Replace Ticagrelor in ACS Treatment?
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients